Haitian Creole Haitian Creole
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Konferans Briefings

Pwen esansyèl ki soti nan NHF 15th Atelye sou Novel teknoloji ak Transfè Gene pou Emofili

Pwen esansyèl ki soti nan NHF 15th Atelye sou Novel teknoloji ak Transfè Gene pou Emofili

Prezante pa: David Lillicrap, MD ak Glenn F. Pierce, MD, PhD
13-14 septanm 2019 • Washington, DC

Imaj


entwodiksyon
Prezante pa Dr Lillicrap

Defi ki asosye ak AAV kòm yon zouti pou livrezon transjeni ki ka geri ou
Prezante pa Dr. Pierce

FDA Konsèy pou Devlopman nan Klinik Terapi sou Hemofilya
Prezante pa Dr. Pierce

Faktè IX Gene Terapi nan klinik esè Mizajou
Prezante pa Dr Lillicrap


Gene Editing ak Terapi selil ki baze sou pou Emofili
Prezante pa Dr. Pierce



Gade devan ak optimis
Prezante pa Dr. Pierce

Faktè VIII jeyan Terapi jeni Terapi
Prezante pa Dr Lillicrap


Premye jenerasyon Terapi Gene pou Emofili
Prezante pa Dr Lillicrap

Repons AAV akouchman vektè
Prezante pa Dr Lillicrap


Pwolonje Terapi Jen pou Timoun ki gen emofil
Prezante pa Dr Lillicrap

Super User
Super User
Back, pou ouvèti
Imaj

Please enable the javascript to submit this form

Enfòmasyon Sou

Sipòte pa sibvansyon edikasyon bay Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, ak uniQure, Inc.

Esansyèl SSL